On February 5, 2016, the 23rd and final participant had their two-month follow-up evaluation in our Phase 2 study of MDMA-assisted psychotherapy for 23 subjects with chronic, treatment-resistant PTSD in Boulder, Colorado. All subjects have now completed active study participation and have proceeded to 12-month long-term follow-up. Long-term follow-up data will provide additional information to guide the design of our upcoming Phase 3 trials. In December 2015, we asked our supporters to help fund the final $44,000 needed to complete this study. The campaign was an inspiring success, raising $66,457 for the research, with the additional funds supporting additional clinical trials of MDMA-assisted psychotherapy for PTSD. The final results will be prepared for publication in early 2016, with publication expected in late 2016.